Innovative Patents for Precise Cancer Diagnosis
EG BioMed focuses on innovative cancer detection technologies and continues to drive its global patent strategy.
Below are the current patent developments, covering detection technologies for breast cancer, pancreatic cancer, colorectal cancer, and lung cancer. Relevant information will be updated periodically.
Breast Cancer Patent Portfolio
2019
Breast cancer technology initiated patent portfolio in Taiwan and internationally.
2021
Obtained Taiwan patent certificate.
2023
Received European Union patent certificate, registered in 19 European countries.
2024
Granted Patents in Malaysia and China.
Other Countries
Patent applications are still under review, expected to receive US patent certificate by the end of 2024.
Pancreatic Cancer Patent Portfolio
2023
Priority declaration completed, and patent deployment initiated in Taiwan and other countries.
Current Status
Patent applications in Taiwan, the United States, and PCT international routes have been completed and are under review.
Colorectal Cancer Patent Portfolio
2021
Launched patent deployment in Taiwan and internationally.
2023
Received the Taiwanese patent certificate.
Current Status
Patent applications in the EU, US, Australia, and other countries are still under review.